Zyprexa maker Eli Lilly has agreed to public disclosure of fees it pays physicians who endorse or educate about their products.
Lilly is the first pharmaceutical to announce it would disclose even if the Physicians Payments Sunshine Act (H.R. 5605) did not become law.
According to a company statement:
the public will have access to an Internet database listing its payments to physicians. Lilly will launch this registry as early as the second half of 2009. When first launched, its contents will include 2009 payments to physicians who serve the company.
There has been growing intolerance for pharma subsidizing physicians with lavish gifts, fees and honoraria. The bill requires disclosure above $500, a level which the industry sought to have increased from the amount originally set at $25. The bill preempts state disclosure laws.
Elsewhere:
Pharmalot
The Carlat Psychiatry Blog
